Summary

These findings challenge current practices using low-power LED devices and suggest a need to revise treatment protocols to ensure adequate power delivery for therapeutic effects. The demonstrated safety and efficacy of high-powered PBM, particularly in treating complex neurological conditions, positions it as a promising non-invasive therapeutic option.

Future development of this technology should focus on optimizing delivery systems while maintaining necessary power levels for effective tissue penetration. Additional controlled clinical trials are warranted to further validate these findings and establish standardized treatment protocols. The potential of PBM as both a primary and adjunctive therapy merits continued investigation, particularly given its favorable risk-benefit profile and the growing need for effective treatments for neurological conditions.

The evidence suggests that when properly implemented with adequate power and appropriate parameters, PBM represents a valuable therapeutic tool that could significantly impact the treatment of various neurological conditions, offering new hope for patients with limited treatment options.